Home of
 

Keywords :   


Tag: of

El Nio Could Usher in a Decade of Stronger Events

2015-12-20 16:01:00| Climate Ark Climate Change & Global Warming Newsfeed

Climate Central: In Buffalo, early December meant breaking a 116-year-old record for a lack of snow. In Duluth, Minn., a newspaper reported that the temperature was 40 degrees above zero, not below. And in Miami, beachgoers stayed indoors during what had become the third-wettest December in local history, just eight days into the month. What's going on with the weather? It's the phenomenon called El Nio, which is happening now as ocean water temperatures rise above normal across the central and eastern Pacific,...

Tags: of events decade stronger

 

The 15 Most Memorable Articles of 2015

2015-12-20 14:00:00| Electrical Construction & Maintenance

As we look back on 2015, so many powerful stories had an impact on the electrical industry. read more

Tags: of articles memorable

 
 

Mercks KEYTRUDA (pembrolizumab) Significantly Improves Survival Compared to Chemotherapy in Previously-Treated Patients with Non-Small Cell Lung Cancer Whose Tumors Express Any Level of PD-L1

2015-12-19 16:55:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. KEYNOTE-010 Published in The Lancet and to be Presented at the European Society for Medical Oncology (ESMO) Asia 2015 Congress KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced results from the pivotal KEYNOTE-010 study, the first study of its kind to evaluate the potential of an immunotherapy compared to chemotherapy based on prospective measurement of PD-L1 expression in patients with advanced non-small cell lung cancer (NSCLC). Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orCourtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: of level express cell

 

Eye cells grown at Johns Hopkins may lead to a cure for some forms of blindness

2015-12-19 10:20:18| Chemicals - Topix.net

Dr Donald Zack, co-director of Center for Stem Cells and Ocular Regenerative Medicine at Johns Hopkins Wilmer Eye Institute, is leading a study that is growing eye cells in the lab and one day could help develop therapies that could stop blindness. Zach shows a cell sorter in his lab at the Smith Building.

Tags: of some lead forms

 

5 Stocks For The Hottest Fashion Trend Of 2016

2015-12-19 05:58:41| Footwear - Topix.net

It used to be that "casual Fridays" and weekend clothing meant one thing: blue jeans. But over the last 10 years, trends have been changing, and a new category of casual clothes has been gaining ground against denim, especially for women.

Tags: of fashion trend stocks

 

Sites : [451] [452] [453] [454] [455] [456] [457] [458] [459] [460] [461] [462] [463] [464] [465] [466] [467] [468] [469] [470] next »